Browsing by UP Author "Nyakale, Nozipho E."

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Browsing by UP Author "Nyakale, Nozipho E."

Sort by: Order: Results:

  • Appropriate indications for positron emission tomography/computed tomography, 2015 
    Vorster, Mariza; Doruyter, A.; Brink, A.; Mkhize, S.; Holness, J.; Malan, N.; Nyakale, Nozipho E.; Warwick, J.M.; Sathekge, Mike Machaba (Health and Medical Publishing Group, 2016-01)
    These recommendations are intended to serve an important and relevant role in advising referring physicians on the appropriate use of 18F-fluorodeoxyglucose (18F-FDG) and non-18F-FDG positron emission tomography/computed ...
  • Blood-brain barrier integrity in a zolpidem-responder patient 
    Nyakale, Nozipho E.; Clauss, Ralf P.; Nel, H.W.; Sathekge, Mike Machaba (Health and Medical Publishing Group, 2012-10)
    A 27-year-old neurologically disabled but fully conscious male zolpidem-responder patient was investigated for blood-brain barrier (BBB) dysfunction 5 years after a traumatic brain injury. A baseline single-photon ...
  • Clinical and brain SPECT scan response to zolpidem in patients after brain damage 
    Nyakale, Nozipho E.; Clauss, Ralf P.; Nel, Wally; Sathekge, Mike Machaba (Editio Cantor Verlag (ECV), 2011)
    Previous reports document transient improvements after daily zolpidem (CAS 82626-48-0) in patients with brain damage. This multi-patient study evaluates the response to zolpidem in neurologically disabled patients, using ...
  • Nuclear medicine-induced allergic reactions 
    Nyakale, Nozipho E.; Lockhat, Zarina I. (Allergy Society of South Africa, 2015-03)
    Immunologic reactions to radiopharmaceuticals are usually mild and transient and require little or no medical treatment. As the usage of radiopharmaceuticals has increased, the reported adverse reactions remain ...